Woman Annoyed When She Gets on Wegovy and It Does Nothing
For some, the issue with GLP-1 drugs like Ozempic and Mounjaro isn't getting access to these game-changing medications, but ...
Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?
The market didn't appreciate Amgen 's ( AMGN 1.00%) latest clinical data update, with the biopharma's shares falling more ...
Medicare Could Pay for Wegovy. Don’t Count On It.
The Biden administration said it would allow the program to pay for GLP-1 anti-obesity drugs, but the Trump administration ...
Eli Lilly and Novo Nordisk’s Obesity Moat Just Got Stronger
Data from their most serious competitor, Amgen, suggests the biotech won’t upstage the market leaders.
Exclusive: Thousands turn to Wegovy copies each month as FDA considers shortage status
More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...
CBS News4d
Thanksgiving may feel different for Americans on weight loss drugs. Here's why.
Those who are on GLP-1 agonists like the diabetes drug Ozempic or weight loss drugs like Zepbound or Wegovy, "can't really overeat the same way, because one of the ways those drugs work is by ...